Skip to content

IAS: Routine HIV testing acceptable to most pregnant women in Zimbabwe

IAS: UN HIV envoy delivers call to action to Rio conference

IAS: Single dose nevirapine for mother doesn't lead to worse CD4 response to HAART

IAS: Hepatitis C treatment should last for 48 weeks in HIV co-infected patients, study shows

IAS: Atazanavir safe and effective during pregnancy

IAS: The New York Patient - source found but mysteries remain

Political, economic and social transition creates HIV risk environment: BMJ article

IL-2 increases CD4 cell counts by prolonging CD4 T-cell survival

New HIV infections in San Francisco may be half of official estimates